122 related articles for article (PubMed ID: 28334841)
21. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
[TBL] [Abstract][Full Text] [Related]
22. Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: A systematic review and meta-analysis.
Scherer JN; Fiorentin TR; Borille BT; Pasa G; Sousa TRV; von Diemen L; Limberger RP; Pechansky F
J Pharm Biomed Anal; 2017 Sep; 143():77-85. PubMed ID: 28577420
[TBL] [Abstract][Full Text] [Related]
23. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
[TBL] [Abstract][Full Text] [Related]
24. Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.
Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
Forensic Sci Int; 2016 Mar; 260():95-101. PubMed ID: 26851651
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
26. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
Lund HM; Øiestad EL; Gjerde H; Christophersen AS
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269
[TBL] [Abstract][Full Text] [Related]
27. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving.
Arroyo A; Sánchez M; Barberia E; Barbal M; Marrón MT; Mora A
Med Leg J; 2013; 81(Pt 3):135-43. PubMed ID: 24057314
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
29. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
Samyn N; De Boeck G; Verstraete AG
J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
[TBL] [Abstract][Full Text] [Related]
30. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
Cone EJ
Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
[TBL] [Abstract][Full Text] [Related]
32. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
33. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests.
Moore L; Wicks J; Spiehler V; Holgate R
J Anal Toxicol; 2001 Oct; 25(7):520-4. PubMed ID: 11599594
[TBL] [Abstract][Full Text] [Related]
34. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Matzopoulos R; Lasarow A; Bowman B
Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
[TBL] [Abstract][Full Text] [Related]
35. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
[TBL] [Abstract][Full Text] [Related]
36. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
[TBL] [Abstract][Full Text] [Related]
37. An up-converting phosphor technology-based lateral flow assay for point-of-collection detection of morphine and methamphetamine in saliva.
Hu Q; Wei Q; Zhang P; Li S; Xue L; Yang R; Wang C; Zhou L
Analyst; 2018 Sep; 143(19):4646-4654. PubMed ID: 30168551
[TBL] [Abstract][Full Text] [Related]
38. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
39. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS.
Cirimele V; Villain M; Mura P; Bernard M; Kintz P
Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544
[TBL] [Abstract][Full Text] [Related]
40. Analysis of drugs of abuse in hair: evaluation of the immunochemical method VMA-T vs. LC-MS/MS or GC-MS.
Baumgartner MR; Guglielmello R; Fanger M; Kraemer T
Forensic Sci Int; 2012 Feb; 215(1-3):56-9. PubMed ID: 22019396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
